IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer
Wang, Shuhang1; An, Tongtong1; Duan, Jianchun1; Zhang, Lijian2; Wu, Meina1; Zhou, Qinghua3; Chen, Jinfeng2; Zhuo, Minglei1; Yang, Lu1; Wang, Yuyan1; Bai, Hua1; Wang, Jie1
刊名PLOS ONE
2013-03-08
DOI10.1371/journal.pone.0051021
8期:3
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Multidisciplinary Sciences
研究领域[WOS]Science & Technology - Other Topics
关键词[WOS]FACTOR RECEPTOR MUTATIONS ; MET AMPLIFICATION ; GEFITINIB ; ERLOTINIB ; TUMORS ; SENSITIVITY ; RESISTANCE
英文摘要

Introduction: Genetic aberrancies within epidermal growth factor receptor (EGFR) pathway are associated with therapeutic outcomes of EGFR-tyrosine kinase inhibitors (TKIs) in advanced non-small cell lung cancer (NSCLC). However, the impact of chemotherapy on EGFR-related genes alterations has not been defined in NSCLC. Our study aims to investigate the impact of neoadjuvant chemotherapy (Neoadj-Chemo) on EGFR activating mutations and associated EGFR-TKIs resistance-related genes.

Patients and Methods: Matched tumor samples were obtained retrospectively from 66 NSCLC patients (stages IIb-IIIb) corresponding to pre-and post-Neoadj-Chemo. EGFR mutations were detected by denaturing high performance liquid chromatography (DHPLC) and confirmed by Amplification Refractory Mutation System technology (ARMS), KRAS mutations, T790M mutation and c-MET amplification were identified using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP), ARMS, and real-time PCR, respectively.

Results: Before Neoadj-Chemo, EGFR mutations were identified in 33.3% (22/66) of NSCLC patients. Only 18.2% (12/66) of patients carried EGFR mutations after Neoadj-Chemo (p = 0.013). The median peak value of EGFR 19 exon mutations decreased non-significantly after Neoadj-Chemo. KRAS mutation rate decreased from 4.6% (3/66) to 3.0% (2/66) with Neoadj-Chemo. Although the overall percentage of patients exhibiting c-MET amplifications (6.1% [4/66]) did not change with Neoadj-Chemo, two patients transitioned from negative to positive c-MET amplification, and two patients reversed these changes post-Neoadj-Chemo. T790M mutations were absent from all samples.

Conclusion: Neoadjuvant chemotherapy tends to decrease the mutation frequency of EGFR mutation and downstream genes, which suggests that real-time samples analysis for genetic aberrancies within EGFR pathways have important value to delineate specific patient populations and facilitate individualized treatment.

语种英语
WOS记录号WOS:000318679900001
项目编号81025012 ; 81172235 ; 2007-1023 ; 2011-2-22 ; Z090507017709015 ; 81101726
资助机构National Natural Sciences Foundation Distinguished Young Scholars ; National Natural Sciences Foundation General Program ; Capital Development Foundation ; Beijing Health Systems Academic Leader ; Science and Technology Project of Beijing ; National Natural Sciences Foundation China Youth Science Foundation
引用统计
被引频次:8[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67459
专题北京大学临床肿瘤学院
北京大学临床肿瘤学院_胸部肿瘤外二科
北京大学临床肿瘤学院_胸部肿瘤内科
作者单位1.Peking Univ, Sch Oncol, Dept Thorac Med Oncol,Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China
2.Peking Univ, Sch Oncol, Dept Thorac Surg,Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China
3.Tianjin Med Univ Gen Hosp, Dept Thorac Surg, Tianjin, Peoples R China
推荐引用方式
GB/T 7714
Wang, Shuhang,An, Tongtong,Duan, Jianchun,et al. Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer[J]. PLOS ONE,2013,8(3).
APA Wang, Shuhang.,An, Tongtong.,Duan, Jianchun.,Zhang, Lijian.,Wu, Meina.,...&Wang, Jie.(2013).Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer.PLOS ONE,8(3).
MLA Wang, Shuhang,et al."Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer".PLOS ONE 8.3(2013).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Shuhang]的文章
[An, Tongtong]的文章
[Duan, Jianchun]的文章
百度学术
百度学术中相似的文章
[Wang, Shuhang]的文章
[An, Tongtong]的文章
[Duan, Jianchun]的文章
必应学术
必应学术中相似的文章
[Wang, Shuhang]的文章
[An, Tongtong]的文章
[Duan, Jianchun]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。